EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease

European Reviews of Chemical Research · 05.12.2020 · 7 (1)

DOI: 10.13187/ercr.2020.1.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Reviews of Chemical Research, online erschienen am 05.12.2020. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2020). Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease. European Reviews of Chemical Research, 7(1). https://doi.org/10.13187/ercr.2020.1.3

Vancouver

Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease. European Reviews of Chemical Research. 2020;7(1). doi:10.13187/ercr.2020.1.3

BibTeX
@article{euvimed2020,
  title = {Molecular Docking Study of Primaquine-Favipiravir Based Compounds as Potential Inhibitors of COVID-19 Main Protease},
  journal = {European Reviews of Chemical Research},
  year = {2020},
  volume = {7},
  number = {1},
  doi = {10.13187/ercr.2020.1.3}
}
Kostenlos starten →